Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System
Clinical trial NCT01777295 · COMPLETED
Trial details
- NCT number
- NCT01777295
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-25
- Primary completion
- 2016-05-17
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.